Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 1990

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 12
Chunk 1990
---
000  
     90,122,000 
  
    Income from operations 
     8,822,000  
     431,000 
  
    Other (expense) income: 

    Interest expense, net 
     (22,786,000) 
     (21,324,000)
  
    Investment (loss) gain from Eton Pharmaceuticals 
     (3,171,000) 
     3,092,000 
  
    Loss on extinguishment of debt 
     -  
     (5,465,000)
  
    Other expense, net 
     (185,000) 
     (444,000)
  
    Total other expense, net 
     (26,142,000) 
     (24,141,000)
  
    Loss before income taxes 
     (17,320,000) 
     (23,710,000)
  
    Income tax expense 
     (161,000) 
     (701,000)
  
    Net loss 
     (17,481,000) 
     (24,411,000)
  
    Basic and diluted net loss per share of common stock 
    $(0.49) 
    $(0.75)
  
    Weighted average number of shares of common stock outstanding, basic and diluted 
     35,650,714  
     32,616,777 

The accompanying notes are an integral part
of these consolidated financial statements

F-6

HARROW, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’
EQUITY

For the Years Ended December 31, 2024 and 2023

    Shares  
    Value  
    Capital  
    Deficit  
    Equity  
    Interests  
    Equity 

    Common Stock  
    Additional  
       
    Harrow Inc.  

    Par  
    Paid-in  
    Accumulated  
    Stockholders’  
    Noncontrolling  
    Stockholders’ 

    Shares  
    Value  
    Capital  
    Deficit  
    Equity  
    Interests  
    Equity 
  
    Balance at January 1, 2023 
     29,901,530  
    $30,000  
    $137,058,000  
    $(109,493,000)